The activities of the NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase from ascites tumor cells are kinetically independent
- PMID: 3258307
The activities of the NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase from ascites tumor cells are kinetically independent
Abstract
The bifunctional NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase from ascites tumor cells has very different kinetic properties from the larger NADP-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase present in all mammalian cells. The NAD-dependent dehydrogenase is unique in that it requires formation of a magnesium.enzyme complex to allow addition of the first substrate, NAD+. It catalyzes an equilibrium ordered kinetic mechanism that has methylenetetrahydrofolate as the last reactant to add and NADH as the last product released. The NADP-dependent dehydrogenase has the same order of addition of substrates, but NADPH is released prior to methenyltetrahydrofolate. The dehydrogenase-cyclohydrolase activities of both enzymes channel methenyltetrahydropteroylglutamate intermediates with the same efficiency which is unaffected by the number of glutamyl residues in the methylenetetrahydrofolate substrate. However, the cyclohydrolase activity of the bifunctional protein is kinetically independent of its dehydrogenase activity, as supported by its lack of inhibition by NAD+, whereas NADP+ strongly inhibits that of the NADP-dependent enzyme. This difference is further demonstrated by the observation that conversion of formyltetrahydrofolate to methylenetetrahydrofolate in the presence of reduced pyridine nucleotide is catalyzed readily only by the bifunctional enzyme.
Similar articles
-
NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase in transformed cells is a mitochondrial enzyme.Biochem Biophys Res Commun. 1988 Aug 30;155(1):1-6. doi: 10.1016/s0006-291x(88)81040-4. Biochem Biophys Res Commun. 1988. PMID: 3261979
-
NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase from ascites tumor cells. Purification and properties.J Biol Chem. 1986 Jul 15;261(20):9509-13. J Biol Chem. 1986. PMID: 3487546
-
Methylenetetrahydrofolate dehydrogenase - methenyltetrahydrofolate cyclohydrolase - formyltetrahydrofolate synthetase from porcine liver: evidence to support a common dehydrogenase-cyclohydrolase site.Can J Biochem Cell Biol. 1983 Nov;61(11):1166-71. doi: 10.1139/o83-150. Can J Biochem Cell Biol. 1983. PMID: 6607769
-
Methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase from porcine liver. Interaction between the dehydrogenase and cyclohydrolase activities of the multifunctional enzyme.Biochim Biophys Acta. 1978 Feb 10;522(2):311-7. doi: 10.1016/0005-2744(78)90065-7. Biochim Biophys Acta. 1978. PMID: 23838
-
Mitochondrial methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetases.Vitam Horm. 2008;79:393-410. doi: 10.1016/S0083-6729(08)00414-7. Vitam Horm. 2008. PMID: 18804703 Review.
Cited by
-
Acetogenesis and the Wood-Ljungdahl pathway of CO(2) fixation.Biochim Biophys Acta. 2008 Dec;1784(12):1873-98. doi: 10.1016/j.bbapap.2008.08.012. Epub 2008 Aug 27. Biochim Biophys Acta. 2008. PMID: 18801467 Free PMC article. Review.
-
The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform-Selective Inhibitors.ChemMedChem. 2022 Sep 16;17(18):e202200274. doi: 10.1002/cmdc.202200274. Epub 2022 Jul 6. ChemMedChem. 2022. PMID: 35712863 Free PMC article.
-
MicroRNA-940 inhibits glioma progression by blocking mitochondrial folate metabolism through targeting of MTHFD2.Am J Cancer Res. 2019 Feb 1;9(2):250-269. eCollection 2019. Am J Cancer Res. 2019. PMID: 30906627 Free PMC article.
-
Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential.Oncogene. 2021 Apr;40(13):2339-2354. doi: 10.1038/s41388-021-01695-8. Epub 2021 Mar 4. Oncogene. 2021. PMID: 33664451 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases